These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
227 related items for PubMed ID: 22318527
1. [Enzyme replacement therapy for Gaucher disease introduced in late adulthood]. Juhász P, Tóth B, Maródi L, Erdos M. Orv Hetil; 2012 Feb 19; 153(7):264-70. PubMed ID: 22318527 [Abstract] [Full Text] [Related]
2. [Gaucher disease: importance of early diagnosis and therapy]. Simon G, Erdos M, Maródi L, Tóth J. Orv Hetil; 2008 Apr 20; 149(16):743-50. PubMed ID: 18426721 [Abstract] [Full Text] [Related]
3. Biochemical and molecular characterization of adult patients with type I Gaucher disease and carrier frequency analysis of Leu444Pro - a common Gaucher disease mutation in India. Sheth J, Pancholi D, Mistri M, Nath P, Ankleshwaria C, Bhavsar R, Puri R, Phadke S, Sheth F. BMC Med Genet; 2018 Oct 01; 19(1):178. PubMed ID: 30285649 [Abstract] [Full Text] [Related]
4. [Enzyme replacement therapy in Gaucher disease: monitoring visceral and bone changes with MRI]. Tóth J, Szücs FZ, Benkö K, Maródi L. Orv Hetil; 2003 Apr 20; 144(16):749-55. PubMed ID: 12778625 [Abstract] [Full Text] [Related]
6. Management of women with Gaucher disease in the reproductive age. Rosenbaum H. Thromb Res; 2015 Feb 20; 135 Suppl 1():S49-51. PubMed ID: 25903536 [Abstract] [Full Text] [Related]
7. The clinical course of untreated Gaucher disease in 22 patients over 10 years: hematological and skeletal manifestations. Piran S, Roberts A, Patterson MA, Amato D. Blood Cells Mol Dis; 2009 Feb 20; 43(3):289-93. PubMed ID: 19793665 [Abstract] [Full Text] [Related]
9. Glucocerebrosidase (Gaucher disease). Beutler E, Gelbart T. Hum Mutat; 1996 Feb 20; 8(3):207-13. PubMed ID: 8889578 [Abstract] [Full Text] [Related]
10. Enzyme Replacement Therapy in a Gaucher Family. Erdem N, Buran T, Berber I, Aydogdu I. J Natl Med Assoc; 2018 Aug 20; 110(4):330-333. PubMed ID: 30126557 [Abstract] [Full Text] [Related]
14. [From gene to disease; Gaucher disease]. Hollak CE, Boot RG, Poorthuis BJ, Aerts JM. Ned Tijdschr Geneeskd; 2005 Sep 24; 149(39):2163-6. PubMed ID: 16223076 [Abstract] [Full Text] [Related]
15. Velaglucerase alfa, a human recombinant glucocerebrosidase enzyme replacement therapy for type 1 Gaucher disease. Pastores GM. Curr Opin Investig Drugs; 2010 Apr 24; 11(4):472-8. PubMed ID: 20336596 [Abstract] [Full Text] [Related]
16. Ambroxol improves skeletal and hematological manifestations on a child with Gaucher disease. Jiang W, Yi M, Maegawa GHB, Zhang H. J Hum Genet; 2020 Mar 24; 65(3):345-349. PubMed ID: 31822786 [Abstract] [Full Text] [Related]
17. Gaucher Disease: Clinical, Biological and Therapeutic Aspects. Dandana A, Ben Khelifa S, Chahed H, Miled A, Ferchichi S. Pathobiology; 2016 Mar 24; 83(1):13-23. PubMed ID: 26588331 [Abstract] [Full Text] [Related]
18. Revised recommendations for the management of Gaucher disease in children. Kaplan P, Baris H, De Meirleir L, Di Rocco M, El-Beshlawy A, Huemer M, Martins AM, Nascu I, Rohrbach M, Steinbach L, Cohen IJ. Eur J Pediatr; 2013 Apr 24; 172(4):447-58. PubMed ID: 22772880 [Abstract] [Full Text] [Related]
19. [Adult Gaucher disease]. Stirnemann J, Belmatoug N. Rev Med Interne; 2001 Dec 24; 22 Suppl 3():374s-383s. PubMed ID: 11794882 [Abstract] [Full Text] [Related]